Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review

Background: In patients with allogenic hematopoietic stem cell transplantation (allo-HSCT), immune-checkpoint inhibitors (ICI) are used to treat malignancy recurrence. However, ICI are also associated with graft vs. host disease (GVHD). In this pharmacovigilance analysis, we aimed to characterize ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Lee S., Raia, Lisa, Lebrun-Vignes, Bénédicte, Salem, Joe-Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892442/
https://www.ncbi.nlm.nih.gov/pubmed/33613286
http://dx.doi.org/10.3389/fphar.2020.619649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892442/
https://www.ncbi.nlm.nih.gov/pubmed/33613286
http://dx.doi.org/10.3389/fphar.2020.619649

Ejemplares similares